Gastric retention for cardiovascular therapy: matching drug properties, dosage-form design, and translational evidence

Hossein Omidian

Open source

DOI
10.1016/j.drudis.2026.104770
Published
2026-09
Container
Drug Discovery Today
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.drudis.2026.104770,
  title = {Gastric retention for cardiovascular therapy: matching drug properties, dosage-form design, and translational evidence},
  author = {Hossein Omidian},
  year = {2026},
  journal = {Drug Discovery Today},
  doi = {10.1016/j.drudis.2026.104770},
  url = {https://doi.org/10.1016/j.drudis.2026.104770}
}

RIS

TY  - JOUR
TI  - Gastric retention for cardiovascular therapy: matching drug properties, dosage-form design, and translational evidence
AU  - Hossein Omidian
PY  - 2026
JO  - Drug Discovery Today
DO  - 10.1016/j.drudis.2026.104770
UR  - https://doi.org/10.1016/j.drudis.2026.104770
ER  - 

APA

Omidian, H. (2026). Gastric retention for cardiovascular therapy: matching drug properties, dosage-form design, and translational evidence. Drug Discovery Today. https://doi.org/10.1016/j.drudis.2026.104770

Source records